CGEM
Ticker
Cullinan Therapeutics, Inc.
CGEM · Healthcare · Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the Unite…Cullinan Therapeutics, Inc. (CGEM), in the Healthcare sector, has 8 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 0 purchases and 8 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 10. The most active filer was Jennifer Michaelson with 6 filings. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
8
0 buys · 8 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$1.7M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 8
Filed Sep 10
ADViAverage daily dollar volume
$20.1M
market data
Share price · 12M
$20.63 (+177.3%)
Adjusted for splits and dividends.
Volume by month
Buys $13.3M
Sells $1.8M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
JMRecent filings
Jennifer MichaelsonSALE
Chief Scientific Officer
$173K8,000 sh × $21.57
Exec Sep 8
Filed Sep 10 · 9:22 AM ET Jennifer MichaelsonSALE Chief Scientific Officer $608K
30,000 sh × $20.26
Exec Aug 13
Filed Aug 14 · 5:00 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $143K
8,000 sh × $17.82
Exec Jul 6
Filed Jul 7 · 5:00 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $114K
7,800 sh × $14.60
Exec May 5
Filed May 6 · 5:30 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $125K
8,000 sh × $15.68
Exec Mar 5
Filed Mar 9 · 5:30 PM ET Nadim AhmedSALE President and CEO $196K
13,515 sh × $14.47
Exec Feb 24
Filed Feb 25 · 5:30 PM ET Nadim AhmedSALE President and CEO $223K
16,381 sh × $13.62
Exec Feb 20
Filed Feb 23 · 5:30 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $114K
8,000 sh × $14.30
Exec Feb 20
Filed Feb 23 · 5:30 PM ET Lynx1 Capital Management LPPURCHASE 10% owner $1.4M
165,667 sh × $8.40
Exec Oct 28 2025
Filed Oct 30 2025 · 5:13 PM ET Lynx1 Capital Management LPPURCHASE 10% owner $2.1M
248,749 sh across 4 lots
Exec Oct 14 2025
Filed Oct 21 2025 · 7:00 PM ET † Lynx1 Capital Management LPPURCHASE 10% owner $9.8M
1,459,641 sh across 3 lots
Exec Oct 8 2025
Filed Oct 10 2025 · 6:58 PM ET Nadim AhmedSALE President and CEO $107K
12,529 sh × $8.53
Exec Feb 25 2025
Filed Feb 27 2025 · 5:30 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $125K
8,000 sh × $15.64
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET